Skip to content

Dr. Cornelia Oetke
Dr. Cornelia Oetke acquired the academic title “Dr. rer. nat.” in biology and is accredited since 2011 as qualified German Patent Attorney and since 2012 as qualified European Patent Attorney.
She joined the WRST team in the beginning of 2017.

Parcours technique
Dr. Oetke gained substantial expertise in advice and representation of clients in the fields of biotechnology, pharmaceutical agents (small molecules, proteins), formulations, antibodies, antibody modifications, biosimilars, vaccines, veterinary products, stem cells, cell culture media, cell culture processes, diagnostic methods and medical applications.

Dr. Oetke studied at and graduated from Ruprecht-Karls-University, Heidelberg. In connection with her diploma thesis and doctorate, respectively, Dr. Oetke conducted researches at the German Cancer Research Center (DKFZ) Heidelberg. From 2003 to 2077, she held a postdoctoral position in the department of cell biology and immunology at the University of Dundee in Great Britain.

Activités juridiques
Dr. Oetke’s fields of work particularly comprise drafting patent applications and prosecuting European and German patent application procedures, enforcement and defense of intellectual property rights, in particular in opposition and nullity proceedings, advising in and conducting of application proceedings for supplementary protection certificate, providing expert opinions in patent infringement, FTO, due diligence and validity cases.

Dr. Oetke joined the WRST team in 2017. Before she worked for many years with a renowned internationally active Munich patent attorney firm.

German, English

German Patent Attorney
European Patent Attorney
European Trademark and Design Attorney

The German Association for the Protection of Intellectual Property (GRUR)
Association of Intellectual Property Experts (VPP)
International Association for the Protection of Intellectual Property (AIPPI)
Licensing Executives Society (LES)

Delputte, PL, Van Breedam W, Delrue I, Oetke C, Crocker PR, Nauwynck HJ (2007) Porcine arterivirus attachment to the macrophage-specific receptor sialoadhesin is dependent on the sialic acidbinding activity of the N-terminal immunoglobulin domain of sialoadhesin.J Virol. 81(17): 9546-9550.

Jiang H-R, Hwenda L, Makinen K, Oetke C, Crocker PR, Forrester JV (2006) Sialoadhesin promotes the inflammatory response in experimental autoimmune uveoretinitis. J. Immunol. 177(14): 2258-62.

Oetke C, Kraal G, Crocker PR (2006) The antigen recognized by MOMA-I is sialoadhesin. Immuno.l Lett. 106(1): 96-8.

Kobsar I, Oetke C, Kroner A, Wessig C, Crocker P, Martini R (2006) Attenuated demyelination in the absence of the macrophage-restricted adhesion molecule sialoadhesin (Siglec-1) in mice heterozygously deficient in P0. Mol. Cell. Neurosci. 31(4): 685-91.

Oetke C, Vinson MC, Jones C, Crocher (2006) Sialoadhesin-deficient mice exhibit subtle changes in B and T cell populations and reduced immunoglobulin M levels. Mol. Cell. Biol. 26(4): 1549-57.

Oetke C, Hinderlich S, Reutter W, Pawlita M (2003) Epigenetically mediated loss of UDP-GlcNAc 2- epimerase/ManNAc kinase expression in hyposialylated cell lines. Biochem. Biophys. Res. Commun. 308(4): 892-8.

Oetke C, Brossmer R, Mantey LR, Hinderlich S, Isecke R, Reutter W, Kep-pler OT, Pawlita M. (2002) Versatile biosynthetic engineering of sialic acid in living cells using synthetic sialic acid analogues. J. Biol. Chem. 277(8): 6688-6695.

Oetke C, Hinderlich S, Brossmer R, Reutter W, Pawlita M, Keppler OT. (2001) Evidence for efficient uptake and incorporation of sialic acid by eu-karyotic cells. Eur. J. Biochem. 268(16): 4553-61.

Oetke C, Auvinen E, Pawlita M, Alonso A. (2000) Human papillomavirus type 16 E5 protein localizes to the Golgi apparatus but does not grossly af-fect cellular glycosylation. Arch. Virol. 145(10): 2183-91.

Go to publications


Dr. rer. nat. Cornelia Oetke

Tel. +49 (0)89-2102320
Fax +49 (0)89-21949408

vCard Download